Testing Linaclotide for Cystic Fibrosis Bowel Function
Part of Digestive system, Genetic & congenital, Lungs & breathing clinical trials.
This early-stage study tests whether a medication called linaclotide can help improve bowel function in people with cystic fibrosis. Researchers will use MRI scans and other tests to see how the medication affects your digestive system.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Between 18 and 60 years old
- Able to undergo MRI scanning without metal implants or pacemakers
- Not pregnant, breastfeeding, or planning pregnancy during the study
- Willing to stop certain medications (like painkillers, anxiety drugs, and some blood pressure medicines) for the study period
- No history of stomach/intestine surgery (except appendix removal) or bowel ostomy
- BMI between 18.5 and 35, and able to follow dietary restrictions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses MRI scans to look at how the drug linaclotide affects the intestines in people with cystic fibrosis. You'll take the drug or a placebo and have MRI scans after eating special meals to see if the drug helps with gut function.
This study uses advanced diagnostic tests to help people whose cystic fibrosis (CF) diagnosis is unclear. It aims to give a clearer answer about whether you have CF or a related condition.
This trial tests how safe and tolerable three different study drugs (SION-451, SION-2222, and SION-109) are when taken together in healthy adults. The goal is to find a good dose combination for future studies in people with cystic fibrosis.
This study tests whether a Mediterranean-style diet can improve gastrointestinal health in children with cystic fibrosis. It requires families to follow the diet for 6 months and attend regular clinic visits.
This study tests whether a special nutrition supplement can help people with cystic fibrosis who also have pancreatic problems. It is for adults 18 and older who are already taking a CFTR modulator and have normal liver lab results.
This trial tests a prescription drug called linaclotide (brand name Linzess) to see how well it works and how safe it is for people with chronic constipation. If you have constipation without a clear cause, this study may offer a treatment option.
Hear when a new Cystic Fibrosis (CF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.